Clover Health officer plans 300K-share, $1.4M sale

Clover Health officer Conrad Wai has filed a Rule 144 notice to sell up to 300,000 CLOV common shares, following a smaller sale in July 2026.

Available on EDGAR 09/15/2026 - 03:58 PM EDT Accepted by SEC EDGAR 09/15/2026 - 03:57 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Clover Health Investments, Corp. (CLOV) has a notice from officer Conrad Wai to sell shares of the company’s common stock under Rule 144. The planned sale covers 300,000 shares of common stock through Merrill Private Wealth Management on or after September 15, 2026, listed on NASDAQ.

The 300,000 shares correspond to multiple tranches of RSUs scheduled to settle in cash and stock between October 31, 2024 and April 30, 2025. The notice also reports that Wai sold 24,215 shares of common stock in the prior three months on July 15, 2026.

Key Figures

Shares to be sold: 300,000 shares Aggregate market value of planned sale: $1,417,021.80 Shares outstanding: 435,441,337 shares +3 more

6 metrics

Shares to be sold 300,000 shares Planned Rule 144 sale of Clover Health common stock by officer Conrad Wai

Aggregate market value of planned sale $1,417,021.80 Aggregate market value listed for the 300,000 shares to be sold

Shares outstanding 435,441,337 shares Clover Health common shares outstanding as referenced in the securities information section

Recent shares sold 24,215 shares Common shares sold on July 15, 2026 during the past three months

Proceeds from recent sale $109,806.84 Total consideration for 24,215 common shares sold on July 15, 2026

Approximate date of proposed sale September 15, 2026 Approximate sale date for the 300,000 shares under Rule 144

Key Terms

Rule 144, restricted stock units, aggregate market value

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock units financial

"Securities To Be Sold section lists "RSU" for each COMMON entry."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

aggregate market value financial

"Securities Information section includes a column for 1,417,021.8 as aggregate market value."

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for CLOV?

It discloses that officer Conrad Wai intends to sell 300,000 shares of Clover Health Investments, Corp. common stock under Rule 144, using Merrill Private Wealth Management, with an approximate sale date of September 15, 2026 on NASDAQ.

How many CLOV shares does Conrad Wai plan to sell under this Form 144?

The filing states a planned sale of 300,000 shares of Clover Health Investments, Corp. common stock. The aggregate market value associated with this amount is listed as $1,417,021.80 at the time of the notice.

What RSU-related CLOV shares are included in the planned Form 144 sale?

The 300,000 planned shares come from RSUs tied to dates of October 31, 2024 (108,504 shares), December 14, 2024 (19,284), January 31, 2025 (30,530), March 14, 2025 (113,275), and April 30, 2025 (28,407).

Were any CLOV shares recently sold by Conrad Wai before this Form 144?

Yes. The notice reports that 24,215 shares of Clover Health common stock were sold on July 15, 2026 for total proceeds of $109,806.84 during the past three months.

How many CLOV shares are outstanding according to this Form 144?

The filing lists 435,441,337 shares of Clover Health Investments, Corp. common stock as outstanding, in the section summarizing the securities information related to the planned Rule 144 sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001971702
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CLOVER HEALTH INVESTMENTS, CORP. /DE
SEC File Number	001-39252
Address of Issuer	30 MONTGOMERY STREET JERSEY CITY NEW JERSEY 07302
Phone	2014322133
Name of Person for Whose Account the Securities are To Be Sold	WAI CONRAD
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	MERRILL PRIVATE WEALTH MANAGEMENT 555 CALIFORNIA STREET, SUITE 1800 SAN FRANCISCO CA 94104	300000	1417021.8	435441337	09/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	10/31/2024	RSU	CLOVER HEALTH INVESTMENTS, CORP			108504	10/31/2024	CASH
COMMON	12/14/2024	RSU	CLOVER HEALTH INVESTMENTS, CORP			19284	12/14/2024	CASH
COMMON	01/31/2025	RSU	CLOVER HEALTH INVESTMENTS, CORP			30530	01/31/2025	CASH
COMMON	03/14/2025	RSU	CLOVER HEALTH INVESTMENTS, CORP			113275	03/14/2025	CASH
COMMON	04/30/2025	RSU	CLOVER HEALTH INVESTMENTS, CORP			28407	04/30/2025	CASH

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
CONRAD WAI 30 MONTGOMERY STREET JERSEY CITY NJ 07302	COMMON	07/15/2026	24215	109806.84

144: Remarks and Signature

Remarks
Date of Notice	09/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/08/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	CONRAD WAI
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)